Forest and Cypress Announce Submission of New Drug Application for … - FOX News
Forest and Cypress Announce Submission of New Drug Application for …
FOX News - Milnacipran is jointly being developed for fibromyalgia syndrome in the United States market by Forest and its licensor, Cypress Bioscience, … |










Leave a Comment